Al-Sofiani, Mohammed E. https://orcid.org/0000-0003-4420-9378
Almehthel, Mohamed
Al Ozairi, Ebaa
Sadik, Jamaa
Hao, Lichen
Akil, Yasser
Funding for this research was provided by:
Sanofi, Paris, France
Article History
Received: 12 February 2025
Accepted: 13 June 2025
First Online: 21 July 2025
Declarations
:
: Mohammed E. Al-Sofiani has served on an advisory panel for Abbott, Medtronic, Insulet, VitalAire, and Sanofi and has received honoraria for speaking and consultancy from Abbott, Eli Lilly, Medtronic, Novo Nordisk, Sanofi, and VitalAire; Mohamed Almehthel and Ebaa Al Ozairi have no conflicts of interest to declare; Jamaa Sadik, Lichen Hao, and Yasser Akil are employees of Sanofi and may hold Sanofi shares and/or stock.
: MDC users agreed to allow their anonymized data to be used retrospectively as part of the registration process. The study was approved by the Institutional Review Board of King Saud University (ref. no. 22/0251 /IRB), Saudi Arabia and Kuwait.